Basic Information
Basic information for PTPRG-AS1-212-35aa
Peptide Name PTPRG-AS1-212-35aa
Genome Position chr3:62261929-62262033[-]
Species Human
Peptide Sequence MPFSCLSLPSSWDYRRLPPRPANFCIFSRDRVSPH
Peptide Length 35
Unique No (PTPRG-AS1-201-35aa,PTPRG-AS1-204-35aa,PTPRG-AS1-205-35aa,PTPRG-AS1-206-35aa,PTPRG-AS1-211-35aa,PTPRG-AS1-213-35aa,PTPRG-AS1-214-35aa,PTPRG-AS1-217-35aa,PTPRG-AS1-218-35aa,PTPRG-AS1-219-35aa,PTPRG-AS1-221-35aa,PTPRG-AS1-222-35aa,PTPRG-AS1-223-35aa,PTPRG-AS1-226-35aa)
Grand Average of Hydropathicity -0.4457
Relative Molecular Mass 4749.23
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000241472;PTPRG-AS1
Transcript ID/Name ENST00000652980;PTPRG-AS1-212
Transcript Length 2682
Coding Ability 0.4351
DNA Sequence Corresponding to Peptide ATGCCATTCTCCTGCCTTAGCCTCCCGAGTAGCTGGGACTACAGGCGCCTGCCACCACGCCCGGCTAATTTTTGTATTTTTAGTAGAGACAGGGTTTCACCGCAT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :